Literature DB >> 26515624

Spinal Muscular Atrophy.

Stephen J Kolb1, John T Kissel2.   

Abstract

Spinal muscular atrophy is an autosomal-recessive disorder characterized by degeneration of motor neurons in the spinal cord and caused by mutations in the survival motor neuron 1 gene, SMN1. The severity of SMA is variable. The SMN2 gene produces a fraction of the SMN messenger RNA (mRNA) transcript produced by the SMN1 gene. There is an inverse correlation between SMN2 gene copy number and clinical severity. Clinical management focuses on multidisciplinary care. Preclinical models of SMA have led to an explosion of SMA clinical trials that hold great promise of effective therapy in the future.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Motor neuron; SMN1; SMN2; Spinal muscular atrophy; Survival motor neuron gene

Mesh:

Substances:

Year:  2015        PMID: 26515624      PMCID: PMC4628728          DOI: 10.1016/j.ncl.2015.07.004

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  76 in total

Review 1.  Special considerations in the respiratory management of spinal muscular atrophy.

Authors:  Mary K Schroth
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

2.  Scoliosis in spinal muscular atrophy: review of 63 cases.

Authors:  E Rodillo; M L Marini; J Z Heckmatt; V Dubowitz
Journal:  J Child Neurol       Date:  1989-04       Impact factor: 1.987

3.  Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation.

Authors:  A H Nickol; N Hart; N S Hopkinson; J Moxham; A Simonds; M I Polkey
Journal:  Thorax       Date:  2005-06-06       Impact factor: 9.139

4.  Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.

Authors:  Jennifer L Taylor; Francis K Lee; Golriz Khadem Yazdanpanah; John F Staropoli; Mei Liu; John P Carulli; Chao Sun; Steven F Dobrowolski; W Harry Hannon; Robert F Vogt
Journal:  Clin Chem       Date:  2014-12-11       Impact factor: 8.327

5.  Bone mineral density in a paediatric spinal muscular atrophy population.

Authors:  M Kinali; L M Banks; E Mercuri; A Y Manzur; F Muntoni
Journal:  Neuropediatrics       Date:  2004-12       Impact factor: 1.947

6.  A natural history study of late onset spinal muscular atrophy types 3b and 4.

Authors:  S Piepers; L H van den Berg; F Brugman; H Scheffer; M Ruiterkamp-Versteeg; B G van Engelen; C G Faber; M de Visser; W-L van der Pol; J H J Wokke
Journal:  J Neurol       Date:  2008-06-30       Impact factor: 4.849

7.  Spinal muscular atrophy: natural history and orthopaedic treatment of scoliosis.

Authors:  C Granata; L Merlini; E Magni; M L Marini; S B Stagni
Journal:  Spine (Phila Pa 1976)       Date:  1989-07       Impact factor: 3.468

8.  Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.

Authors:  Yimin Hua; Timothy A Vickers; Hazeem L Okunola; C Frank Bennett; Adrian R Krainer
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

Review 9.  Chaperoning ribonucleoprotein biogenesis in health and disease.

Authors:  Livio Pellizzoni
Journal:  EMBO Rep       Date:  2007-04       Impact factor: 8.807

10.  A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo.

Authors:  Alexa Dickson; Erkan Osman; Christian L Lorson
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 4.793

View more
  101 in total

1.  Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy.

Authors:  Caroline J Woo; Verena K Maier; Roshni Davey; James Brennan; Guangde Li; John Brothers; Brian Schwartz; Susana Gordo; Anne Kasper; Trevor R Okamoto; Hans E Johansson; Berhan Mandefro; Dhruv Sareen; Peter Bialek; B Nelson Chau; Balkrishen Bhat; David Bullough; James Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  Trembling hands and trembling ECG.

Authors:  Indar Kumar Sharawat; Thakurvir Singh Kohli; Lokesh Saini
Journal:  BMJ Case Rep       Date:  2019-06-02

3.  SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.

Authors:  Marie-Therese Khairallah; Jacob Astroski; Sarah K Custer; Elliot J Androphy; Craig L Franklin; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

4.  Spinal Muscular Atrophy: The Treatment Approved.

Authors:  Rabih Tabet; Sandy El Bitar; Julie Zaidan; Garbis Dabaghian
Journal:  Cureus       Date:  2017-09-02

Review 5.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.

Authors:  Alicia J Angelbello; Jonathan L Chen; Jessica L Childs-Disney; Peiyuan Zhang; Zi-Fu Wang; Matthew D Disney
Journal:  Chem Rev       Date:  2018-01-11       Impact factor: 60.622

6.  Novel PGD strategy based on single sperm linkage analysis for carriers of single gene pathogenic variant and chromosome reciprocal translocation.

Authors:  Yuqian Wang; Xiaohui Zhu; Zhiqiang Yan; Xu Zhi; Shuo Guan; Ying Kuo; Yanli Nie; Ying Lian; Jin Huang; Yuan Wei; Ping Liu; Rong Li; Jie Qiao; Liying Yan
Journal:  J Assist Reprod Genet       Date:  2020-04-29       Impact factor: 3.412

7.  Establishing a reference dataset for the authentication of spinal muscular atrophy cell lines using STR profiling and digital PCR.

Authors:  Deborah L Stabley; Jennifer Holbrook; Ashlee W Harris; Kathryn J Swoboda; Thomas O Crawford; Katia Sol-Church; Matthew E R Butchbach
Journal:  Neuromuscul Disord       Date:  2017-02-06       Impact factor: 4.296

Review 8.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

9.  An Evidence-Based, Community-Engaged Approach to Develop an Interactive Deliberation Tool for Pediatric Neuromuscular Trials.

Authors:  Rebecca R Moultrie; Megan A Lewis; Ryan S Paquin; Ann Lucas; Jill Jarecki; Holly L Peay
Journal:  J Genet Couns       Date:  2017-12-20       Impact factor: 2.537

Review 10.  Biology and clinical relevance of noncoding sno/scaRNAs.

Authors:  Thuy Cao; Sheeja Rajasingh; Saheli Samanta; Buddhadeb Dawn; Douglas C Bittel; Johnson Rajasingh
Journal:  Trends Cardiovasc Med       Date:  2017-08-12       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.